Fujita M, Taguchi T
Gan To Kagaku Ryoho. 1982 Apr;9(4):606-15.
The usefulness of the nude mouse-human cancer xenograft system for a sensitivity test of chemotherapeutic drugs is evaluated. In our present study, the response of 9 experimental chemotherapies on 7 lines of cancer xenografts in nude mice was directly compared with clinical response in each donor patient, to the same chemotherapy and good correlation was found between these respective results. Experimental studies on chemotherapeutic effects on 14 lines of cancer xenografts (7 gastric, 3 colorectal, 3 breast and 1 pancreatic cancer) using 5 clinically active and 5 new drugs, were also conducted Although every line of xenograft retained different patterns of sensitivity to the various agents, drugs which were clinically effective to a type of tumor were found to be also sensitive against the same type of xenografts in nude mice. Thus the nude-mice human cancer system were is thought to be useful as a predictive secondary screening for new drugs. However, further improvement is necessary to establish this system as a more accurate selection method for anti-cancer drugs.
评估了裸鼠-人癌异种移植系统在化疗药物敏感性测试中的实用性。在我们目前的研究中,将9种实验性化疗对裸鼠体内7种癌异种移植瘤的反应与每个供体患者对相同化疗的临床反应进行了直接比较,发现这些各自的结果之间具有良好的相关性。还使用5种临床活性药物和5种新药对14种癌异种移植瘤(7种胃癌、3种结直肠癌、3种乳腺癌和1种胰腺癌)进行了化疗效果的实验研究。尽管每种异种移植瘤对各种药物保留不同的敏感性模式,但发现对某一类型肿瘤临床有效的药物对裸鼠体内相同类型的异种移植瘤也敏感。因此,裸鼠-人癌系统被认为可作为新药预测性二次筛选的有用工具。然而,要将该系统确立为更准确的抗癌药物筛选方法,还需要进一步改进。